Management Andragogics 2: Zurich Living Case
At a time when managers often provide fodder for unseemly headlines, and some are even compared unflatteringly with locusts, today’s business leaders are called upon as never before to demonstrate the moral justification for their activities, and to ensure that it is understood by all the key stakeholders of a company. What is required is nothing less than a management renaissance, based on a thoroughgoing concept of corporate leadership; there is no less a need for decision makers who hold themselves to the highest standards, with a positive perception of their fu- tion as agents of dissemination, and who are committed to the good not only of “their” firm, but also of society in general. Particularly in today’s environment of significant movements of goods, the hi- est priority is accorded to the social and labor policy elements of company m- agement. For its part, the State must create advantageous framework conditions and promote the willingness to accept risk that is fundamental to the entrepren- rial spirit. A social, constitutional state with a liberal social structure has always been and remains the prime concern of democratically spirited forces everywhere. When managers live up to the expectations with which they are entrusted, they lend the social market economy – often misunderstood and sometimes even m- used – a new luster. This in turn fulfils the hopes and expectations of those Eu- peans for whom the development of pan-European structures stands for the rec- ery from post-communist stagnation.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Selection of Study Participants
The Zurich Living Case Study
The Master Plan Thesis
Practical Implementation of Lessons Learned
Course Overview HRM Block for GSBA Zurich 73
Zurich Living Case
Solution to the Zurich Living Case
TABLE OF CONTENTS
ORGANIZATIONAL STRUCTURE 18
AIM OF THE STUDY 24
IDENTIFICATION OF BEST IN CLASS 38
activities actual patients Artikel AS/P-ratio assessment audit Benchmarking MAF best in class best practices Cilag clinical trial processes closure Notification communication company’s competitive cost Country CP/AP-ratio DCF’s Drug supply employees evaluation focus topic function GGCS Heilmitteln VKlin IEC approval impact implementation improve innovation internal investigator Janssen Pharmaceutica Janssen-Cilag AG Jörg job rotation Johnson & Johnson key performance indicators Klinische Versuche KPI’s Läuffer line managers measures Medical & Regulatory Medical Affairs Metrics monitor multiplication factors Notification to IEC ORANGE plc ORANGE SA ORANGE Switzerland organization participation manager patients/1 mil residents performance gap pharmaceutical pharmacovigilance phase rationale of KPI’s recruiting rate Regulatory Affairs regulatory authority regulatory body SAE-handling senior management sites/1 mil residents solution Southwest Airlines study block study participants Swiss Swisscom Table transfer Verordnung über Klinische Versuche mit Heilmitteln Zurich Living